About Delta-9 Tetrahydrocannabinol
Delta-9 Tetrahydrocannabinol (D9 THC) is the primary psychoactive compound in cannabis, responsible for its intoxicating effects. It binds to cannabinoid receptors in the brain and body. Founded in cannabis research, D9 THC's discovery dates back to the mid-20th century, and its potential therapeutic effects include pain relief, euphoria, appetite stimulation, relaxation, and more.
Broad spectrum CBD contains various cannabinoids and terpenes found in the cannabis plant, except for THC. This means it offers potential therapeutic effects without the psychoactive properties of THC. On the other hand, full spectrum CBD contains all cannabinoids, including THC, but in trace amounts (below 0.3% in legal products). Full spectrum CBD users may experience the entourage effect, where cannabinoids work synergistically for enhanced benefits, including potential pain relief, relaxation, and anti-inflammatory effects. However, broad spectrum CBD eliminates any risk of THC-related intoxication while still providing potential health benefits similar to full spectrum CBD. Both types offer diverse potential effects depending on individual physiology and the specific formulation.